Corpus Intelligence IC Memo — MCLEOD MEDICAL CENTER - DILLON 2026-04-26 05:27 UTC
IC Memo — MCLEOD MEDICAL CENTER - DILLON
Investment Committee Memorandum | SC | 72 beds | Grade C | EBITDA uplift $3.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MCLEOD MEDICAL CENTER - DILLON

CCN 420005 | DILLON, SC | 72 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MCLEOD MEDICAL CENTER - DILLON is a 72-bed suburban community hospital in DILLON, SC with $53.2M in net patient revenue and a 11.0% operating margin. The hospital serves a payer mix of 24.5% Medicare, 5.9% Medicaid, and 69.6% commercial.

Thesis: Turnaround. Our ML models identify $3.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 11.0% to 18.4% (+736bps).

Net Revenue HCRIS$53.2M
Current EBITDA COMPUTED$5.9M
Operating Margin COMPUTED11.0%
Occupancy HCRIS30.0%
Revenue / Bed COMPUTED$739K
Net-to-Gross HCRIS18.5%
Distress Probability ML52.4%

2. Market Context & Competitive Position

85
SC Hospitals
1.3%
State Median Margin
46
Comparable Hospitals

SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of 11.0% places it above the state median. Among 46 size-comparable peers (36-144 beds), the median margin is 5.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (36-144), prioritizing same-state peers. 46 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MCLEOD MEDICAL CENTER - DILLON (Target)SC72$53.2M11.0%
PH PATEWOOD HOSPITALSC64$229.8M38.0%
EAST COOPER REGIONAL MEDICAL CSC120$206.1M28.3%
OCONEE MEMORIAL HOSPITALSC131$190.4M5.2%
WACCAMAW COMMUNITY HOSPITALSC124$182.8M2.7%
GEORGETOWN MEMORIAL HOSPITALSC68$168.0M-4.6%
HILTON HEAD HOSPITALSC109$165.7M29.2%
PH GREER MEMORIAL HOSPITALSC66$161.3M31.3%
PH BAPTIST PARKRIDGE HOSPITALSC78$159.8M18.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.1M+210bp18mo
Cost to Collect4.5%2.5%$1.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$647K+122bp9mo
Clean Claim Rate88.0%96.0%$34K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.1M
Cost to Collect
$1.1M
Denial Rate Reduction
$1.1M
A/R Days Reduction
$647K
Clean Claim Rate
$34K
Total EBITDA Uplift$3.9M
Current EBITDA$5.9M
+ RCM Uplift+$3.9M
Pro Forma EBITDA$9.8M
Current Margin11.0%
Pro Forma Margin18.4%
WC Released (1x)$2.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$9.0M$77.9M8.62x53.8%
Base (11x exit)10.0x11.0x$9.0M$88.7M9.81x57.9%
Bull Case9.0x11.0x$8.1M$104.5M12.85x66.6%
Bull (12x exit)9.0x12.0x$8.1M$116.4M14.31x70.3%
Bear Case11.0x10.0x$9.9M$55.4M5.57x41.0%
Bear (11x exit)11.0x11.0x$9.9M$64.2M6.45x45.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 30.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 52.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 46 hospitals with 36-144 beds
  • Same-state prioritization (n=47)
  • Comp margins: P25=-7.0% / P50=5.2% / P75=17.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.